Finanzwire Finanzwire
Basculer en Français
9979 Companies
202294 Keywords
132920 Articles
107424 Press releases
Headlines Articles Press releases Tanvex BioPharma USA, Inc. Remove
  1. Home
  2. Companies
  3. Tanvex BioPharma USA, Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 08/19/2024 at 13:05, 1 year 6 months ago

    Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05

    FDA Approval Cancer Treatment Healthcare Innovation Biosimilar Neutropenia
  • PRESS RELEASE

    published on 08/19/2024 at 13:00, 1 year 6 months ago

    Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05

    Tanvex BioPharma USA, Inc. receives FDA approval for NYPOZI™ biosimilar and FDA BLA acceptance for TX-05, showcasing expertise in biologics development and manufacturing
    FDA Approval Biologics Tanvex BioPharma NYPOZI TX-05
    Logo of Tanvex BioPharma USA, Inc.
  • PRESS RELEASE

    published on 10/16/2023 at 14:00, 2 years 4 months ago

    Tanvex CDMO Launch Empowers Advancements in Novel Biologics and Biosimilars

    Logo of Tanvex BioPharma USA, Inc.
Accesswire
  • Published on 03/05/2026 at 13:40, 18 minutes ago

    Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences

  • Published on 03/05/2026 at 13:30, 28 minutes ago

    Vox Royalty Provides 2026 Guidance and Increases Quarterly Dividend

  • Published on 03/05/2026 at 13:30, 28 minutes ago

    Nextech3D.ai Expands AI Event Technology Into New Markets and Implements 20%-30% Enterprise Price Increase

  • Published on 03/05/2026 at 13:00, 58 minutes ago

    Revolve Signs Definitive Agreements for Portfolio of 16 Distributed Generation Solar Projects in Mexico

  • Published on 03/05/2026 at 13:00, 58 minutes ago

    Field Work Identifies New Mineralized Trend and Additional Gold Targets at Golden Rose

View all ACCESSWIRE
EQS Group
  • Published on 03/05/2026 at 13:43, 15 minutes ago

    Healthcare specialist SHS Capital exits AMW, a leading specialty pharma company, and continues partnership by reinvesting with its current fund as part of a syndicate of investors

  • Published on 03/05/2026 at 13:25, 33 minutes ago

    Huawei and SOLUM Unveil Shop-in-Shop Smart Converged Network Solution to Accelerate Retail Intelligence

  • Published on 03/05/2026 at 13:06, 51 minutes ago

    HENSOLDT acquires Nedinsco and expands its European presence

  • Published on 03/05/2026 at 13:05, 53 minutes ago

    Norgine announces £23 million new investment as part of more than £50 million committed to expanding medicines manufacturing in Wales

  • Published on 03/05/2026 at 13:00, 58 minutes ago

    Huawei Launches AI Data Platform to Bridge Models and Business Value

View all EQS
Les Echos
  • Published on 03/05/2026 at 13:20, 38 minutes ago

    Voting rights

  • Published on 03/05/2026 at 07:30, 6 hours 28 minutes ago

    Share buyback finalized

  • Published on 03/04/2026 at 23:50, 14 hours 8 minutes ago

    Total number of voting rights and shares making up the share capital at February 28, 2026

  • Published on 03/04/2026 at 18:00, 19 hours 58 minutes ago

    Disclosure of Share Capital and Voting Rights as of February 28, 2026

  • Published on 03/04/2026 at 17:45, 20 hours 13 minutes ago

    MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy